Japan’s drug maker to begin Covid-19 vaccine Phase 3 clinical trial in Vietnam
The clinical trial is aimed at putting its "recombinant protein vaccine" on the list of the World Health Organization-approved vaccines.
The clinical trial is aimed at putting its "recombinant protein vaccine" on the list of the World Health Organization-approved vaccines.
The license might be issued in the final trial that is expected to last two months from June.